Ottawa – The Government of Canada is committed to working with partners and stakeholders across the country in support of the global goal of ending viral hepatitis, HIV and other sexually transmitted and blood-borne infections (STBBI) as public health threats. The contribution of community-based organizations is central to Canada’s ability to achieve these targets. Projects funded by the HIV and Hepatitis …
INDIANAPOLIS – Eli Lilly and Company (NYSE: LLY) today announced updated clinical data from the international Phase 1/2 BRUIN trial of pirtobrutinib, a non-covalent (reversible) Bruton’s tyrosine kinase (BTK) inhibitor, in adult patients with a range of B-cell malignancies. These data, which were presented in oral and poster presentations at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition, continue to …
